Subsequently, disruption of monocytic production in BM of SMM and MM patients would lead to a deficient production and release of recently formed CD62L+ cMo into blood and thereby, decreased numbers of circulating cMo. The gene discussed is SELL; the disease is Miyoshi myopathy.